Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent

Renin-angiotensin-aldosterone system blockade has been shown to protect against renal damage in salt-supplemented, stroke-prone spontaneously hypertensive rats (SHRsp). Based on intermittent tail-cuff blood pressure (BP) measurements, it has been claimed that such protection is BP-independent and mediated by a blockade of the direct tissue-damaging effects of angiotensin and/or aldosterone. BP radiotelemetry was performed for 8 weeks in approximate to10-week-old male SHRsp who received a standard diet and either tap water (n=10) or 1% NaCl to drink. Saline-drinking SHRsp were either left untreated (n = 12), received enalapril (50 mg/L) in drinking fluid (n = 9), or had subcutaneous implantation of time-release 200-mg pellets of aldactone (n = 10). The average systolic BP (mean +/- SEM) during the final 3 weeks was significantly higher (P<0.05) in untreated saline-drinking (215 +/- 6 mm Hg) SHRsp but not aldactone-treated (198 +/- 4 mmHg) or enalapril-treated treated SHRsp (173 +/- 1 mmHg), as compared with tap water-drinking SHRsp (197 +/- 3 mm Hg). Histological renal damage scores at 8 weeks paralleled the BP in all groups, with an excellent correlation (r=0.8, P<0.001, n=41). Moreover, a renal damage score of >5 was only observed in SHRsp whose average systolic BP during the final 3 weeks exceeded 200 mm Hg, indicating a threshold relation with BP. These data show that protection by renin-angiotensin-aldosterone system blockade in this model is BP-dependent and mediated by preventing the severe increases in BP seen in untreated salt-supplemented SHRsp and further underscore the limitations of interpretations based on conventional tail-cuff BP measurements.